Larimar Therapeutics LRMR
NASDAQ LRMR
$2.42 -0.02 (-0.82%)
At close: Oct 21, 2026 · 4:00 PM EDT

Larimar Therapeutics (LRMR) Other financing activities (2013 - 2020)

Updated

Larimar Therapeutics (LRMR) posted Other financing activities of $49,000 for FY2014.

Analysis

Larimar Therapeutics (LRMR) Other financing activities (2013 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Larimar Therapeutics 252.95 Mn -354.12 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -60,000.00
Sep 30, 2020 -3,000.00
Jun 30, 2020 -495,000.00
Mar 31, 2020 -738,000.00
Mar 31, 2015 -473,000.00
Sep 30, 2014 -894,000.00
Jun 30, 2014 -640,000.00
Mar 31, 2014 -827,000.00
Dec 31, 2013 -31,000.00
API Access

Larimar Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=LRMR&period=max&api_key=YOUR_API_KEY